Koers Co-Diagnostics, Inc.
Aandelen
CODX
US1897631057
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,11 USD | -0,45% | +0,91% | -16,54% |
15/03 | Co-Diagnostics, Inc. Benoemt Richard Abbott tot President | CI |
14/03 | Transcript : Co-Diagnostics, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Omzet 2024 * | 5,82 mln. 5,4 mln. | Omzet 2025 * | - | Marktkapitalisatie | 34,7 mln. 32,19 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -31 mln. -28,76 mln. | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 5,96 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,12
x | K/w-verhouding 2025 * |
-
| Werknemers | 155 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,25% |
Recentste transcriptie over Co-Diagnostics, Inc.
1 dag | -0,45% | ||
1 week | +0,91% | ||
Lopende maand | -1,77% | ||
1 maand | -1,77% | ||
3 maanden | -21,83% | ||
6 maanden | +3,74% | ||
Lopend jaar | -16,54% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dwight Egan
CEO | Chief Executive Officer | 70 | 18-04-13 |
Brian Brown
DFI | Director of Finance/CFO | 48 | 22-02-21 |
Mark Poritz
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Reed L. Benson
LAW | General Counsel | 77 | 01-11-14 |
Richard Serbin
BRD | Director/Board Member | 79 | 01-05-17 |
Dwight Egan
CEO | Chief Executive Officer | 70 | 18-04-13 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.37% | 29 M€ | -0,55% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 1,11 | -0,45% | 39 810 |
26-03-24 | 1,115 | 0,00% | 52 554 |
25-03-24 | 1,115 | -5,51% | 96 906 |
22-03-24 | 1,18 | +0,85% | 47 049 |
21-03-24 | 1,17 | +6,36% | 53 068 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,54% | 34,7 mln. | |
+11,46% | 23,71 mld. | |
-34,52% | 3,23 mld. | |
+12,64% | 1,79 mld. | |
+0,27% | 1,67 mld. | |
+39,04% | 1,38 mld. | |
-3,60% | 1,11 mld. | |
-20,26% | 915 mln. | |
-4,05% | 738 mln. | |
-14,00% | 716 mln. |